Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...

Pirtobrutinib had a nominally superior overall response rate compared to ibrutinib in certain patients with chronic ...

EUROPEAN shares logged their biggest daily rise in over two weeks on Thursday, boosted by financial stocks as investors ...

The Dow and S&P 500 eased on Thursday, as shares of Eli Lilly dropped after data from its oral weight loss drug disappointed, ...

Eli Lilly’s new weight-loss daily pill underperformed against competitors in weight... The Competition and Consumer ...